Wednesday, April 1, 2020

Fujifilm announced Tuesday that it's beginning phase III trials for its flu drug, Avigan, in coronavirus patients in Japan. It interferes with flu's ability to replicate, and may for COVID-19 too.

from U.S. Home | Mail Online https://ift.tt/39x3NMY

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner